Clinical Trial Update: Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 single-dose, 2-way crossover study in healthy volunteers to evaluate the effect of food on the pharmacokinetics of HCP1201.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• HCP1201

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED